Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.815    0.11 (2.34%)
Bid:
4.755
Ask:
4.80
Spread: 0.045 (0.946%)
Market Cap: £231.10m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Major Industry Awards Win

10 Apr 2006 09:19

Seeing Machines Limited10 April 2006 Seeing Machines Limited ("Seeing Machines" or the "Company") Monday 10 April 2006 Seeing Machines Wins Major Industry Awards for Glaucoma Project Seeing Machines (AIM:SEE) was awarded two iAwards at the AIIA's galapresentation dinner last Friday night (7 April) for its glaucoma diagnosticdevice development. • The "Local Industry Award" - for the most innovative ICT project undertaken by an Australian local industry company (small-to-medium enterprise), and • The "Research and Development Award" - for the most outstanding ICT R& D project The iAwards, Australia's premier industry awards for the Information andCommunications Technology (ICT) sector, are awarded by the AustralianInformation Industry Association (AIIA) for outstanding ICT solutions across 15categories from Agriculture & Primary Industries, e-Government & Service,Research & Development through to Tourism & Hospitality. In addition there arefive major awards: the Local Industry Award, Community Award, InnovativeCommercial Software Award, the Inspiration Award and the CSIRO Tony BensonAward. Seeing Machines won the iAward for the Research and Development category, andthen also picked up the major Local Industry Award for the most innovative ICTproject undertaken by an Australian SME. Seeing Machines is developing the world's first non-contact objective device fordiagnosing glaucoma and a range of other eye diseases, utilising itsmarket-leading, patent-protected computer vision technology. These nationalawards recognize the progress that has been made to date in this project and thesignificant commercial opportunity arising from the pioneering work of theSeeing Machines team and its colleagues at the Research School of BiologicalSciences at the Australian National University. Seeing Machines would like tothank the AIIA for its recognition of this important work. The full list of iAwards is available at: www.aiia.com.au/i-cms.isp?page=1290. -- ends -- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Simon Fox Justine Howarth / Victoria Thomas+61 (0) 2 6125 6501 +44 (0) 20 7190 7018 +44 (0) 20 7493 3713www.seeingmachines.com About the AIIA and the iAwards Details about the Australian Information Industry Association (AIIA) areavailable here: www.aiia.com.au/i-cms.isp?page=13 Details about the iAwards are available here: www.aiia.com.au/i-cms.isp?page=243. About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on visionbased human machine interfaces. Formed in 2000 in Canberra, Australia, SeeingMachines' purpose is to commercialise its computer-vision across a range ofindustries and applications. Seeing Machines deliver advanced computer vision solutions for researches anddeveloper in human factors, transportation safety, computer human interaction,robotics, medical research and psychology. The flagship product faceLABTMprovides an automated and contact-free gaze and head tracking technology, itsolves the problem of observing human behaviour naturally, non-intrusively andwith a high degree of accuracy and usability. faceLABTM is a computer vision system that is able to measure the orientationand position of a human head, as well as detect blinks and estimategaze-direction. It achieves all of this completely visually through a stereocamera system connected to advanced image processing software, with noattachments required on the subject. The product is designed to allow humanfactors researchers and designers assess the interaction of an operator in anenvironment and this finds application in designing operator environments, suchas cockpits for cars, trucks, trains, and aeroplanes for instance, and otherindustrial design applications, as well as medical and psychological researchsituations. The technology also has application in monitoring automobiledrivers and if it detects drowsiness or that the driver is distracted and theirattention has been diverted from the road, an alarm can be raised to alert thedriver to either pull over and rest in the case of drowsiness or to pay moreattention to the road. faceLABTM works in real-time, enabling the behaviour of a subject to be tracked.This technology is paving the way in promoting safer driving conditions andworks to enhance the driving experience and to eliminate accidents causedthrough driver drowsiness or distraction. There are many different sectors that can benefit from this revolutionarysoftware, for which it has been developed, including: automotive; academicresearch; medicine/healthcare; defence; autostereoscopy (next generationdisplays); sport; and games. Seeing Machines is currently working with researchers from the Research Schoolof Biological Sciences at the Australian National University to enable a newobjective method for diagnosing and managing glaucoma, a leading source ofblindness. This technology could complement or replace existing visual fieldtesting devices used by more than 70,000 ophthalmologists globally and may haveapplication in detecting other eye and neurological diseases. Seeing Machinesis developing a technology based on a completely objective method that uses aninvoluntary physiological response. This has the potential to become a 'goldstandard' in the diagnosis and management of glaucoma to derive reliable,repeatable results and greater diagnostic accuracy. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jan 20247:00 amRNSSeeing Machines unveils latest Guardian technology
3rd Jan 20247:00 amRNSSeeing Machines to showcase technology at CES 2024
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding
11th Apr 202311:15 amRNSPDMR Shareholding
6th Apr 20232:45 pmRNSDirector/PDMR Shareholding
5th Apr 20239:08 amRNSPDMR Shareholding
31st Mar 202312:26 pmRNSPDMR Shareholding
29th Mar 202311:55 amRNSDirector/PDMR Shareholding
28th Mar 202311:28 amRNSPDMR Shareholding
27th Mar 202310:12 amRNSDirector/PDMR Shareholding
27th Mar 202310:07 amRNSDirector/PDMR Shareholding
24th Mar 202311:56 amRNSPDMR Shareholding
24th Mar 20238:59 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.